ERBB2 and breast carcinoma: The role of top2A and erb-B2 in breast cancer is well-known; top2A is an enzyme that catalyzes functions in DNA replication and is a molecular target for many anti-cancer drugs (topo2 inhibitors); erb-B2 is amplified frequently in breast cancer and is an independent prognostic target.